The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking therapies, and adoptive T-cell transfer, researchers have started to focus on the overall immunobiology of neoplastic cells. It is now clear that cancer cells can succumb to some anticancer therapies by undergoing a peculiar form of cell death that is characterized by an increased immunogenic potential, owing to the emission of the so-called "damage-associated molecular patterns" (DAMPs). The emission of DAMPs and other immunostimulatory factors by cells succumbing to immunogenic cell death (ICD) f...
Tumor development and growth are under the control of the immune system in the human body. Danger-as...
International audienceIt is now clear that human neoplasms form, progress, and respond to therapy in...
A new concept of immunogenic cell death (ICD) has recently been proposed. The immunogenic characteri...
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of ef...
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of ef...
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of ef...
Cancer immunosurvelliance usually leads to formation of cancer cells that have been "immunoedited" t...
Currently, it is widely acknowledged that a proactive anticancer immunosurveillance mechanism takes ...
Immunogenic Cell Death (ICD) could represent the keystone in cancer management since tumor cell deat...
Immunogenic cell death (ICD) elicited by cancer therapy reshapes the tumor immune microenvironment. ...
Immunogenic profile of certain cancer cell death mechanisms has been transmuted by research publishe...
Immunogenic cell death (ICD), which is triggered by exposure of tumor cells to a limited range of an...
The immunogenicity of cancer cells is an emerging determinant of anti-cancer immunotherapy. Beyond d...
Cell death resistance is a key feature of tumor cells. One of the main anticancer therapies is incre...
Immunogenic profile of certain cancer cell death mechanisms has been transmuted by research publishe...
Tumor development and growth are under the control of the immune system in the human body. Danger-as...
International audienceIt is now clear that human neoplasms form, progress, and respond to therapy in...
A new concept of immunogenic cell death (ICD) has recently been proposed. The immunogenic characteri...
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of ef...
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of ef...
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of ef...
Cancer immunosurvelliance usually leads to formation of cancer cells that have been "immunoedited" t...
Currently, it is widely acknowledged that a proactive anticancer immunosurveillance mechanism takes ...
Immunogenic Cell Death (ICD) could represent the keystone in cancer management since tumor cell deat...
Immunogenic cell death (ICD) elicited by cancer therapy reshapes the tumor immune microenvironment. ...
Immunogenic profile of certain cancer cell death mechanisms has been transmuted by research publishe...
Immunogenic cell death (ICD), which is triggered by exposure of tumor cells to a limited range of an...
The immunogenicity of cancer cells is an emerging determinant of anti-cancer immunotherapy. Beyond d...
Cell death resistance is a key feature of tumor cells. One of the main anticancer therapies is incre...
Immunogenic profile of certain cancer cell death mechanisms has been transmuted by research publishe...
Tumor development and growth are under the control of the immune system in the human body. Danger-as...
International audienceIt is now clear that human neoplasms form, progress, and respond to therapy in...
A new concept of immunogenic cell death (ICD) has recently been proposed. The immunogenic characteri...